The Development of Clinical Guidelines for the Use of Zuclopenthixol Acetate

Barnes, Caryl; Alderton, Deirdre

doi:10.1046/j.1440-1665.2002.00397.x

Cited by 9 publications

(9 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Flowchart for the pharmacological management of acute behavioural disturbance in psychosis. Barnes et al, (2002). Adapted from Castle et al, (2012).…”

Section: Section 3 Treatment: Context Structure and Content Of Intementioning

confidence: 99%

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

Galletly

Castle

Dark

et al. 2016

Aust N Z J Psychiatry

Self Cite

643

672

View full text Add to dashboard Cite

Objectives: This guideline provides recommendations for the clinical management of schizophrenia and related disorders for health professionals working in Australia and New Zealand. It aims to encourage all clinicians to adopt best practice principles. The recommendations represent the consensus of a group of Australian and New Zealand experts in the management of schizophrenia and related disorders. This guideline includes the management of ultra-high risk syndromes, first-episode psychoses and prolonged psychoses, including psychoses associated with substance use. It takes a holistic approach, addressing all aspects of the care of people with schizophrenia and related disorders, not only correct diagnosis and symptom relief but also optimal recovery of social function. Methods:The writing group planned the scope and individual members drafted sections according to their area of interest and expertise, with reference to existing systematic reviews and informal literature reviews undertaken for this guideline. In addition, experts in specific areas contributed to the relevant sections. All members of the writing group reviewed the entire document. The writing group also considered relevant international clinical practice guidelines. Evidence-based recommendations were formulated when the writing group judged that there was sufficient evidence on a topic. Where evidence was weak or lacking, consensus-based recommendations were formulated. Consensus-based recommendations are based on the consensus of a group of experts in the field and are informed by their agreement as a group, according to their collective clinical and research knowledge and experience. Key considerations were selected and reviewed by the writing group. To encourage wide community participation, the Royal Australian and New Zealand College of Psychiatrists invited review by its committees and members, an expert advisory committee and key stakeholders including professional bodies and special interest groups. RANZCP GuidelinesGalletly et al. 411 Australian & New Zealand Journal of Psychiatry, 50(5)Results: The clinical practice guideline for the management of schizophrenia and related disorders reflects an increasing emphasis on early intervention, physical health, psychosocial treatments, cultural considerations and improving vocational outcomes. The guideline uses a clinical staging model as a framework for recommendations regarding assessment, treatment and ongoing care. This guideline also refers its readers to selected published guidelines or statements directly relevant to Australian and New Zealand practice. Conclusions:This clinical practice guideline for the management of schizophrenia and related disorders aims to improve care for people with these disorders living in Australia and New Zealand. It advocates a respectful, collaborative approach; optimal evidence-based treatment; and consideration of the specific needs of those in adverse circumstances or facing additional challenges.

show abstract

“…Flowchart for the pharmacological management of acute behavioural disturbance in psychosis. Barnes et al, (2002). Adapted from Castle et al, (2012).…”

Section: Section 3 Treatment: Context Structure and Content Of Intementioning

confidence: 99%

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

Galletly

Castle

Dark

et al. 2016

Aust N Z J Psychiatry

Self Cite

643

672

View full text Add to dashboard Cite

show abstract

“…In contrast, prescriber surveys have found that it was considered first-line in an antipsychotic-naive patient, and was usually given in combination with another psychoactive medication. 9,20 Barnes et al also found that zuclopenthixol acetate administration was not always in accordance with best practice or the manufacturer's instructions. 9 Rapid tranquillisation guidelines promote a stepwise progression: Step 1.…”

Section: Literature and Guideline Reviewmentioning

confidence: 99%

“…9,20 Barnes et al also found that zuclopenthixol acetate administration was not always in accordance with best practice or the manufacturer's instructions. 9 Rapid tranquillisation guidelines promote a stepwise progression: Step 1. Non-medication measures; Step 2.…”

Section: Literature and Guideline Reviewmentioning

confidence: 99%

Developing Clinical Practice Guidelines for the Medication Management of Acute Behavioural Disturbance

Wheeler¹,

Sheridan

Robinson³

et al. 2007

Pharmacy Practice and Res

View full text Add to dashboard Cite

This paper describes the development process of a concise, portable clinical practice guideline for the medication management of acute behavioural disturbance in adult psychiatric inpatients in Auckland, New Zealand. It was developed to aid psychiatry registrars and is a decision aid only. A literature search identified evidence‐based reviews and guidelines implemented elsewhere. This formed the basis for development of a locally relevant tool, finalised for implementation by a process of consensus agreement. This clinical practice guideline was developed collaboratively over 2 years in response to local need. Development was requested by junior medical staff and actively supported by clinical leaders. The guideline resulted from a review of the evidence for medication management of acute behavioural disturbance and adaptation of the UK National Institute for Clinical Excellence guidance in combination with local consensus agreement.

show abstract

“…Clopixol acuphase is reserved for specific clinical scenarios, and should ideally be a prescribed course of treatment, as articulated elsewhere 16 . Intravenous antipsychotics and benzodiazepines are not advocated due to the greater risk of adverse effects, although in some clinical scenarios (e.g.…”

Section: Guidelinesmentioning

confidence: 99%

Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosis

et al. 2005

Self Cite

View full text Add to dashboard Cite

show abstract

The Development of Clinical Guidelines for the Use of Zuclopenthixol Acetate

Cited by 9 publications

References 10 publications

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

Developing Clinical Practice Guidelines for the Medication Management of Acute Behavioural Disturbance

Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosis

Contact Info

Product

Resources

About